相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse
Nicole M. Enman et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Ketamine as a Novel Antidepressant: From Synapse to Behavior
J. W. Murrough
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Ketamine for Treatment-Resistant Unipolar Depression Current Evidence
Sanjay J. Mathew et al.
CNS DRUGS (2012)
Signaling pathways underlying the rapid antidepressant actions of ketamine
Ronald S. Duman et al.
NEUROPHARMACOLOGY (2012)
Roles of glutamate signaling in preclinical and/or mechanistic models of depression
Kenichi Tokita et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine
Ming-Huan Chan et al.
SCHIZOPHRENIA RESEARCH (2012)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases
Amar S. et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine
Kenji Hashimoto
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
E. Beurel et al.
MOLECULAR PSYCHIATRY (2011)
Social Isolation-Induced Aggression Potentiates Anxiety and Depressive-Like Behavior in Male Mice Subjected to Unpredictable Chronic Mild Stress
Xian-cang Ma et al.
PLOS ONE (2011)
The role of glutamate on the action of antidepressants
Kenji Hashimoto
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
N-methyl-D-aspartate Glutamate Receptor Antagonists and the Promise of Rapid-Acting Antidepressants
John H. Krystal
ARCHIVES OF GENERAL PSYCHIATRY (2010)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice
Jonathan S. Miller et al.
BRAIN RESEARCH BULLETIN (2010)
The involvement of GSK3β in bipolar disorder: Integrating evidence from multiple types of genetic studies
J. J. Luykx et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Glutamatergic Modulators: The Future of Treating Mood Disorders?
Carlos Zarate et al.
HARVARD REVIEW OF PSYCHIATRY (2010)
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis
Rodrigo Machado-Vieira et al.
BIPOLAR DISORDERS (2009)
Emerging role of glutamate in the pathophysiology of major depressive disorder
Kenji Hashimoto
BRAIN RESEARCH REVIEWS (2009)
Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling
Yingwei Mao et al.
CELL (2009)
Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response
Wolfgang Block et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Cocaine-induced hyperactivity and sensitization are dependent on GSK3
Jonathan S. Miller et al.
NEUROPHARMACOLOGY (2009)
Ketamine and the next generation of antidepressants with a rapid onset of action
Rodrigo Machado-Vieira et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Glutamate-based antidepressants: 20 years on
Phil Skolnick et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice
Angelo O. Rosa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
The role of Akt-GSK-3β signaling and synaptic strength in phencyclidine-induced neurodegeneration
Gang Lei et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Increased levels of glutamate in brains from patients with mood disorders
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2007)
Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation
M-L Selenica et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy
Gregor Hasler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Correlation between plasma levels of glutamate, alanine and serine with severity of depression
Hideaki Mitani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS
P Willner
NEUROPSYCHOBIOLOGY (2005)
The ascent of mouse: Advances in modelling human depression and anxiety
JF Cryan et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Forced swimming test in mice: a review of antidepressant activity
B Petit-Demouliere et al.
PSYCHOPHARMACOLOGY (2005)
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus
O Kaidanovich-Beilin et al.
BIOLOGICAL PSYCHIATRY (2004)
Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression
G Sanacora et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
TD Gould et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Preclinical models: Status of basic research in depression
EJ Nestler et al.
BIOLOGICAL PSYCHIATRY (2002)
In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3β in neuronal apoptosis:: links to tau phosphorylation
W Elyaman et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Limitations on the use of the C57BL/6 mouse in the tail suspension test
AJ Mayorga et al.
PSYCHOPHARMACOLOGY (2001)
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
MP Coghlan et al.
CHEMISTRY & BIOLOGY (2000)
Reduced glutamate in the anterior cingulate cortex in depression:: An in vivo proton magnetic resonance spectroscopy study
DP Auer et al.
BIOLOGICAL PSYCHIATRY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
